These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 7808485)

  • 1. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.
    Cao Y; Qin L; Zhang L; Safrit J; Ho DD
    N Engl J Med; 1995 Jan; 332(4):201-8. PubMed ID: 7808485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.
    Pantaleo G; Menzo S; Vaccarezza M; Graziosi C; Cohen OJ; Demarest JF; Montefiori D; Orenstein JM; Fox C; Schrager LK
    N Engl J Med; 1995 Jan; 332(4):209-16. PubMed ID: 7808486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus.
    Kloosterboer N; Groeneveld PH; Jansen CA; van der Vorst TJ; Koning F; Winkel CN; Duits AJ; Miedema F; van Baarle D; van Rij RP; Brinkman K; Schuitemaker H
    Virology; 2005 Aug; 339(1):70-80. PubMed ID: 15987650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.
    Gibellini D; Vitone F; Schiavone P; Ponti C; La Placa M; Re MC
    J Clin Virol; 2004 Apr; 29(4):282-9. PubMed ID: 15018857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of long-term survivors of human immunodeficiency virus type 1 infection.
    Cao Y; Qin L; Zhang L; Safrit J; Ho DD
    Immunol Lett; 1996 Jun; 51(1-2):7-13. PubMed ID: 8811338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort.
    Learmont JC; Geczy AF; Mills J; Ashton LJ; Raynes-Greenow CH; Garsia RJ; Dyer WB; McIntyre L; Oelrichs RB; Rhodes DI; Deacon NJ; Sullivan JS
    N Engl J Med; 1999 Jun; 340(22):1715-22. PubMed ID: 10352163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.
    Clark SJ; Saag MS; Decker WD; Campbell-Hill S; Roberson JL; Veldkamp PJ; Kappes JC; Hahn BH; Shaw GM
    N Engl J Med; 1991 Apr; 324(14):954-60. PubMed ID: 1900576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual phasic suppression of viral replication following de novo human immunodeficiency virus type 1 (HIV-1) infection in lymphocytes of asymptomatic HIV-1 carriers.
    Kannagi M; Nakamura T; Akari H; Kuroda MJ; Fujii M; Oka S; Iwamoto A; Kurata T; Higashi D; Harada S
    Leukemia; 1997 Apr; 11 Suppl 3():545-7. PubMed ID: 9209452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virologic and host characteristics of human immunodeficiency virus type 1-infected pediatric long term survivors.
    Alexander L; Cuchura L; Simpson BJ; Andiman WA
    Pediatr Infect Dis J; 2006 Feb; 25(2):135-41. PubMed ID: 16462290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection.
    Henrard DR; Daar E; Farzadegan H; Clark SJ; Phillips J; Shaw GM; Busch MP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):305-10. PubMed ID: 7788430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.
    Daar ES; Moudgil T; Meyer RD; Ho DD
    N Engl J Med; 1991 Apr; 324(14):961-4. PubMed ID: 1823118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to infection by HIV-1 of peripheral blood mononuclear cells from HIV-1-infected patients is probably mediated by neutralizing antibodies.
    Tremblay M; Numazaki K; Li XG; Gornitsky M; Hiscott J; Wainberg MA
    J Immunol; 1990 Nov; 145(9):2896-901. PubMed ID: 1698866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
    Harrer T; Harrer E; Kalams SA; Barbosa P; Trocha A; Johnson RP; Elbeik T; Feinberg MB; Buchbinder SP; Walker BD
    J Immunol; 1996 Apr; 156(7):2616-23. PubMed ID: 8786327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.
    Furtado MR; Callaway DS; Phair JP; Kunstman KJ; Stanton JL; Macken CA; Perelson AS; Wolinsky SM
    N Engl J Med; 1999 May; 340(21):1614-22. PubMed ID: 10341273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
    Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups.
    Dornadula G; Nunnari G; Vanella M; Roman J; Babinchak T; DeSimone J; Stern J; Braffman M; Zhang H; Pomerantz RJ
    J Infect Dis; 2001 Jun; 183(11):1682-7. PubMed ID: 11343220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between the presence of anti-Tat antibody, DNA and RNA viral load.
    Re MC; Gibellini D; Furlini G; Vignoli M; Vitone F; Bon I; La Placa M
    New Microbiol; 2001 Jul; 24(3):207-15. PubMed ID: 11497076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.